Quantitative reverse-transcriptase-polymerase chain reaction (qPCR)
The total RNA extraction and qPCR procedures were performed as previously described.
1 method was used to analyze relative gene expression levels. The primer sequences were as follows: P4HA1, FW 5′-CAGAAGTACGAAATGCTG-TGCCG-3′, RV 5′-G CTTGTCCCATTCATCCTCCTGTT-3′, product length 145 bp. GAPDH, FW 5′-CTGGGCTACACTGAGCACC-3′, RV 5′-AAGTGGTCGTTGA-GGGCAATG-3′, product length 101 bp.
Western blotting
Protein extraction and western blotting were performed as previously described. 1 The primary antibodies anti-P4HA1 (1:200, ab127564, Abcam, Cambridge, UK), anti-VEGF-A (1:300, ab183100, Abcam), anti-VEGF165b (1:200, MAB3045, R&D), anti-GAPDH (1:2000, ab181602, Abcam), anti-collagen IV (1:1000, ab6586, Abcam) were used to detect protein expression.
Flow cytometry and cell sorting
Flow cytometry was performed using a cell sorter to screen out CD133+ GSCs from the U87MG cell line. Anti-human CD133 antibody (Miltenyi) was used to stain and sort positive GSCs as previously described.
2 Mouse phycoerythrin-IgG1 (Miltenyi) was used as an isotype control.
Cell proliferation
Cell proliferation was determined with a cell counting kit-8 assay (Dojindo).GSCs were initially pretreated with Accutase and then seeded into 96-well plates at a density of 3000 cells per well in 100 µl medium. The cells were cultured for 1-7 days under hypoxic conditions, 10 µl of CCK8 solution was added to each well of the plate for 1 hour, and the absorbance at 450 nm was measured using a microplate reader. All data are presented as the mean ± SD from three experiments.
Cell migration assay
A total of 5×10 4 GSCs were seeded onto the upper compartment of a Transwell plate (24-well, 8 µm pore size, Corning) in 200 µl of serum-free DMEM, and the lower compartment was filled with 600 µl of 5% FBS medium. After incubation in the hypoxic N 2 -O 2 incubator for 8 hours, cells on the upper surface of the membrane were undetectable, and the migrated cells on the lower surface were stained with 1% cresyl violet. The colored cells were counted, and all data represented the mean ± SD from three experiments.
Tube formation assay
The reduced growth factor basement membrane matrix (Geltrex, A1413202, Invitrogen) was thawed overnight at 4°C, and 50 µl/cm 2 /well of Geltrex was placed in 24-well plates without dilution. After incubating at 37°C for 30 minutes, 1.5×10 5 GSCs/well diluted in 1 ml of 10% FBS medium were seeded on the solidified gel. All plates were incubated in the hypoxic N 2 -O 2 incubator for 3 days. Images were randomly captured using a microscope (Olympus, Tokyo, Japan) with 100× magnification. Mesh numbers, mean mesh size, total mesh area, branch numbers, total branching length and total branch length were measured per field with ImageJ software (NIH website).
Immunohistochemistry, immunofluorescence and assessment
Immunohistochemical staining of human glioma samples, animal brain and subcutaneous tumors was performed as described before.
1 P4HA1, Ki67, hCD34 and collagen IV were detected by the following antibodies: anti-human P4HA1 (1:500, ab127564, Abcam), antihuman Ki67 (1:400, ab16667, Abcam), anti-human CD34 (1:100, sc-7324, Santa Cruz, CA, USA, it does not react with mouse-originated vessels), and anti-collagen IV (1:500, ab6586, Abcam). Five images from each slice were randomly captured with a camera (Jenoptik, Jena, Germany) coupled to a microscope (Zeiss, Oberkochen, Germany) at 400× magnification. Expression levels of P4HA1, Ki67 and collagen IV were analyzed with Image Pro Plus software 5.0 (IPP) (Media Cybernetics). Density mean, area sum, and integrated optical density (IOD) were determined. The levels of microvessel density (MVD) were assessed by hCD34 antibody binding following the principles described previously. 3 Five fields (0.079 mm 
Establishment of intracranial and subcutaneous GSC tumor models
Four-to six-week-old BALB/c-nu mice were purchased from Beijing HFK Bioscience Ltd. Animal experiments were approved by Experimental Animal Ethics Committee of Beijing Neurosurgical Institute and were carried out in accordance with the NIH Guide for the Care and Use of Laboratory Animals. After being anesthetized with isoflurane, mice were stabilized in a stereotactic apparatus (KOPF940). A total of 5 × 10 5 GSCs were injected into the brain to establish intracranial tumor models as previously described. 5 To establish subcutaneous GSCs tumor models, 1×10
6 GSCs in 100 μl PBS were injected directly into the dorsal subcutaneous tissue close to the right forelimb. Subcutaneous tumor size was measured every 3 days with a vernier caliper, and tumor volume was calculated as follows: V = π/6 × Length × Width 2 (mm 3 ).
Magnetic resonance imaging (MRI)
Mice were continuously anesthetized with isoflurane and were examined using a 7.0T/30 cm small-animal MRI scanner (Bruker BioSpin, Billerica, MA, USA). T2-weight (T2W) images were acquired using a rapid acquisition with relaxation enhancement (RARE) pulse sequence (axial view: TR = 3380 ms, TE = 41 ms, matrix = 320×256, slice thickness = 0.5 mm; coronal view: TR = 4030 ms, TE = 50 ms, matrix = 320×384, slice thickness = 0.3 mm). The maximal anteroposterior diameter (L), transverse diameter (W) and height (H) were measured with OsiriX software. Tumor volume was calculated as follows: V = π/6×L×W×H (mm
